Aggressive systemic mastocytosis: midostaurin is safe, feasible and associated with durable response post‐haploidentical allogeneic stem cell transplant-Reference-Cited by-同舟云学术

Aggressive systemic mastocytosis: midostaurin is safe, feasible and associated with durable response post‐haploidentical allogeneic stem cell transplant

Published:2019-05-21 Issue:5 Volume:186 Page:
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Martynova Anastasia¹,Nael Ali²,O`Neill Caitlin³,Ramsingh Giridharan³^ORCID,Merchant Akil³,Yaghmour Bassam⁴,Yaghmour George³^ORCID

Affiliation:

1. Department of Medicine University of Southern California Keck School of Medicine of USC Los Angeles CA USA

2. Department of Pathology University of California Irvine Children Hospital of Orange County Los Angeles CA USA

3. Jane Anne Nohl Division of Hematology and Center for the Study of Blood Diseases Keck School of Medicine of USC USC Norris Comprehensive Cancer Center Los Angeles CA USA

4. Pulmonary, Critical Care University of Southern California Keck School of Medicine of USC Los Angeles CA USA

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.15980

Reference5 articles.

1. Midostaurin in Advanced Systemic Mastocytosis

2. Midostaurin: a novel therapeutic agent for patients with FLT3-mutated acute myeloid leukemia and systemic mastocytosis

3. Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis

4. Consensus Opinion on Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis

5. How I treat patients with advanced systemic mastocytosis

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allogeneic haematopoietic cell transplantation for advanced systemic mastocytosis: Best practice recommendations on behalf of the EBMT Practice Harmonisation and Guidelines Committee;Leukemia;2024-03-12

2. Hematopoietic Cell Transplantation in Rare Hematologic Malignancies;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024

3. Advanced systemic mastocytosis—Revised classification, new drugs and how we treat;British Journal of Haematology;2023-12-06

4. Antibody-Based and Cell Therapies for Advanced Mastocytosis: Established and Novel Concepts;International Journal of Molecular Sciences;2023-10-12

5. National clinical recommendations for the diagnosis and treatment of mastocytosis;Russian journal of hematology and transfusiology;2021-09-02